# FDA Inspection 1103496 - Michael R. Liebowitz, M.D. - September 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/michael-r-liebowitz-md/4931a3f3-aad4-47b2-92f2-29e0e9049f2c
Source feed: FDA_Inspections

> FDA Inspection 1103496 for Michael R. Liebowitz, M.D. on September 12, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1103496
- Company Name: Michael R. Liebowitz, M.D.
- Inspection Date: 2019-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1310418 - 2026-03-27](https://www.keypedia.com/records/fda_inspections/michael-r-liebowitz-md/13c5a068-3848-4589-9d29-da5ba2bb7ef9)

Company: https://www.keypedia.com/companies/michael-r-liebowitz-md/2a86aaef-fa52-49f4-aa54-1b5a45a0bc23

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
